Efficacy and safety of berberine for dyslipidaemias: A systematic review and meta-analysis of randomized clinical trials

Borenstein, 2009 Catapano, 2016, 2016 ESC/EAS guidelines for the management of dyslipidaemias, Eur. Heart J., 37, 2999, 10.1093/eurheartj/ehw272 Chait, 2016, Lipids, lipoproteins, and cardiovascular disease: clinical pharmacology now and in the future, J. Clin. Endocrinol. Metab., 101, 804, 10.1210/jc.2015-3940 Chen, 2015, Clinical observation of alginate diester sodium combined with berberine in treatment of 56 patients with type 2 diabetes mellitus complicated hyperlipidemia, Health World, 32, 94 Chen, 2015, Simvastatin combined berberine in patients with coronary artery disease and hypercholesteremia, Central South Pharm., 13, 203 Chen, 2007, Clinical observation of 24 cases of impaired glucose tolerance treated by Liuwei Dihuang pills combined berberine, Jiangsu J. Tradition. Chn. Med., 12, 31 Cicero, 2016, Berberine and its role in chronic disease, Adv. Exp. Med. Biol., 928, 27, 10.1007/978-3-319-41334-1_2 Cicero, 2017, Lipid lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel, AMS, 13, 965 D'Addato, 2017, Effect of a food supplement containing berberine, monacolin K, hydroxytyrosol and coenzyme Q10 on lipid levels: a randomized, double-blind, placebo controlled study, Drug Design Develop. Therapy, 11, 1585, 10.2147/DDDT.S128623 Gerards, 2015, Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain - a systematic review and meta-analysis, Atherosclerosis, 240, 415, 10.1016/j.atherosclerosis.2015.04.004 Gou, 1995, Berberine in treating 59 cases of hyperlipidemia, People's Milit. Surg., 02, 35 He, 2017, Clinical observation of berberine hydrochloride combined with metformin in treatment of type 2 diabetes mellitus with hyperlipidemia, J. North Pharm., 10, 91 He, 2007, Efficacy of simvastatin and berberine hydrochloride in the treatment of hyperlipidemia and carotid atherosclerosis, Tianjin Med. J., 35, 539 Higgins, 2011 Ju, 2007, Effects of berberine hydrochloride liposomes on patients with imparied glucose tolerance complicated with hyperlipidemia, J. Pract. Tradition. Chn. Med., 23, 490 Kong, 2004, Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins, Nature Med., 10, 1344, 10.1038/nm1135 Kong, 2008, Combination of simvastatin with berberine improves the lipid-lowering efficacy, Metabol.-Clinic. Experiment., 57, 1029, 10.1016/j.metabol.2008.01.037 Koppen, 2017, Efficacy of berberine alone and in combination for the treatment of hyperlipidemia: a systematic review, J. Eviden.-Base. Complement. Altern. Med., 22 Kumar, 2015, Current knowledge and pharmacological profile of berberine: An update, Eur. J. Pharmacol., 761, 288, 10.1016/j.ejphar.2015.05.068 Kuo, 2004, The anti-inflammatory potential of berberine in vitro and in vivo, Cancer Lett., 203, 127, 10.1016/j.canlet.2003.09.002 Laird, 1990, Some statistical methods for combining experimental results, Int. J. Technol. Assess. Health Care, 6, 5, 10.1017/S0266462300008916 Lan, 2015, Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension, J. Ethnopharmacol., 161, 69, 10.1016/j.jep.2014.09.049 Law, 2006, Statin safety: a systematic review, Am. J. Cardiol., 97, 52C, 10.1016/j.amjcard.2005.12.010 Liberati, 2009, The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration, BMJ (Clinical Research Ed.), 339, b2700, 10.1136/bmj.b2700 Li, 2015, Analysis of 81 cases of hyperlipemia treated with Xuezhikang and Berberine, J. Math. Med., 07, 1046 Ma, 2007, Observation of the berberine therapy combined Vitamin E nicotinate in 78 patients with coronary artery disease complicated dyslipidemia, Chn. J. Cardiovasc. Rehab. Med., 03, 297 Moher, 2010, CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials, J. Clin. Epidemiol., 63, e1, 10.1016/j.jclinepi.2010.03.004 Mollica, A., Zengin, G., Locatelli, M., Stefanucci, A., Mocan, A., Macedonio, G., Carradori, S., Onaolapo, O., Onaolapo, A., Adegoke, J., Olaniyan, M., Aktümsek, A., Novellino, E., 2017. Anti-diabetic and anti-hyperlipidemic properties of Capparis spinosa L.: In vivo and in vitro evaluation of its nutraceutical potential. Mollica, A., Zengin, G., Stefanucci, A., Ferrante, C., Menghini, L., Orlando, G., Brunetti, L., Locatelli, M., Dimmito, M., Novellino, E., Olayemi K, W., Mustapha O, O., Onaolapo, A., Onaolapo, O., 2018. Nutraceutical potential of Corylus avellana daily supplements for obesity and related dysmetabolism. Onakpoya, 2014, The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials, NMCD, 24, 823 Ried, 2013, Effect of garlic on serum lipids: an updated meta-analysis, Nutr. Rev., 71, 282, 10.1111/nure.12012 Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol., 63, 2889, 10.1016/j.jacc.2013.11.002 Su, 2012, Clinical study on of 60 cases of hyperlipidemia treated with simvastatin combined with Berberine, Chn. Med. Mod. Dist. Edu. Chn., 149, 41 Wang, 2016, Therapeutic effects of berberine capsule on patients with mild hyperlipidemia, Chn. J. Integ. Tradition. West. Med., 36, 681 Wang, 2001, Berberine in treating 39 cases of hyperlipidemia, J. Binzhou Med. Univ., 02, 157 Wang, 2017, Gut microbiota-mediated personalized treatment of hyperlipidemia using berberine, Theranostics, 7, 2443, 10.7150/thno.18290 Wang, 2013, Effect of berberine on carotid intima-media thickness in patients with dyslipidemia and comparison with simvastatin, Chn. J. Integrat. Med. Cardio-/Cerebrovasc. Dis., 11, 871 Wang, 2008, A comparative study of berberine and simvastatin in the treatment of hyperlipidemia, J. Cardiovas. Pulmon. Dis., 03, 128 Wu, 2007, Clinical observe of effect of regulating hyperlipidemia and weight reduction by berberine and oryzanol, J. Clin. Cardiol., 08, 576 Yu, 2007, Observation of 50 cases of hyperlipidemia treated by low dose simvastatin in combination with berberine, Shandong Med. J., 47, 39 Zhan, 2015, Effects of berberine on T2DM and high lipid serum NO level in patients with hyperlipidemia and the activity of SOD, J. North Pharm., 119 Zhang, 2016, Therapeutic potential and mechanisms of berberine in cardiovascular disease, Curr. Pharmacol. Rep., 2, 281, 10.1007/s40495-016-0070-1 Zhang, 2008, Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine, J. Clin. Endocrinol. Metabol., 93, 2559, 10.1210/jc.2007-2404 Zheng, 2009, The therapeutic effects of combination of simvastatin with berberine on the patients with hyperlipemia, J. Nanjing Med. Univ. (Natur. Sci.), 29, 1493 Zhou, J, 2014. Application of berberine hydrochloride combined with metformin in treatment of diabetic hyperlipidemia. XINXUEGUANBING FANGZHI ZHISHI, 68–69. Zhou, 2011, Clinical observation of 60 cases of hyperlipidemia treated by berberine, Chn. J. Clin. Ration. Drug Use, 04, 76 Zhu, 2015